Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities

Snow R. W., 2005, Nature, 434, 217, 10.1038/nature03356

World Health Organization, 2001, Trends Parasitol., 17, 588, 10.1016/S1471-4922(01)02147-X

Hastings I. M, 2004, Trends Parasitol., 512, 518

Biot C., 2006, Novel Approaches to Antimalarial Drug Discovery Curr. Drug Targets − Infectious Disorders

Tripathi R. P., 2005, Curr. Med. Chem., 12, 2659, 10.2174/092986705774370673

Biagini G. A., 2005, Curr. Opin. Pharmacol., 5, 478, 10.1016/j.coph.2005.05.004

Biot C., 2004, Agents

Pink, 2005, Nature Rev. Drug Discovery, 4, 740, 10.1038/nrd1824

Pierrot C., 2005, Int. J. Parasitol., 35, 1610, 10.1016/j.ijpara.2005.07.007

Biot C., 2005, Pharm., 2, 193

Daher W. E., 2006, vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum. Drug Metab. Dispos., 10.1124/dmd.104.003202

Warhurst D. C., 2003, J. Antimicrob. Chemother, 52, 193, 10.1093/jac/dkg319

Savarino A., 2001, J. Clin. Virol., 20, 135, 10.1016/S1386-6532(00)00139-6

Romanelli F., 2004, Curr. Pharm. Des., 10, 2648, 10.2174/1381612043383791

Savarino A., 2004, J. Acquir. Immune Defic. Syndr., 35, 232, 10.1097/00126334-200403010-00002

Owen A., 2005, J. Pharmacol. Exp. Ther., 314, 1209, 10.1124/jpet.105.086272

Vincent M. J., 2005, Virol. J., 2, 69, 10.1186/1743-422X-2-69

Peiris J. S. M., 2003, Coronavirus as a Possible Cause of Severe Acute Respiratory Syndrome Lancet

Ksiazek T. G., 2003, Engl. J. Med., 348, 1966, 10.1056/NEJMoa030781

Drosten C., 2003, N. Engl. J. Med., 348, 1976, 10.1056/NEJMoa030747

He J.-F., 2004, Science, 303, 1669, 10.1126/science.1094515

Guan Y., 2003, Science., 302, 278, 10.1126/science.1087139

Shie J. J., 2005, J. Med. Chem., 48, 4473

Savarino A., 2003, Lancet Infect. Dis., 3, 727, 10.1016/S1473-3099(03)00806-5

Keyaerts E., 2004, Biochem. Biophys. Res. Commun, 323, 268, 10.1016/j.bbrc.2004.08.085

Aderounmu A. F, 1984, Ann. Trop. Med. Parasitol., 78, 585, 10.1080/00034983.1984.11811868

Wei Y., 1995, Chirality, 7, 604

Biot C., 1999, Bioorg. Med. Chem., 7, 2847, 10.1016/S0968-0896(99)00224-2

For, 2006, E. Potential antivirals and antiviral strategies against SARS (severe acute respiratory syndrome)-coronavirus infections. Expert. Rev. Anti-Infective Ther.

De Clercq E., 1980, J. Infect. Dis., 141, 574, 10.1093/infdis/141.5.563

De Clercq E, 1985, Antimicrob. Agents Chemother., 28, 89

Pauwels R., 1987, J. Virol. Methods, 16, 185, 10.1016/0166-0934(87)90002-4

Durrand V., 2004, Mol. Biochem. Parasitol., 136, 285, 10.1016/j.molbiopara.2004.03.016

Desjardins R. E., 1979, Antimicrob. Agents Chemother., 16, 718, 10.1128/AAC.16.6.710